Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
iQure Pharma Logo
iQure Pharma Growth Score
62
CB Rank
26042
Heat Score
72
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Founded
obfuscation
PrivateVenture - Series Unknown Wilmington, Delaware, United States1-10 www.iqurepharma.com/
Biotechnology
Pharmaceutical
Therapeutics
Overview

iQure Pharma
Total Funding
obfuscation
Growth Score
62
Heat Score
72

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score62
-3 pts
in past quarter
Heat Score 72
17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About iQure Pharma

CB Rank
26042
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Founded
obfuscation
PrivateVenture - Series Unknown Wilmington, Delaware, United States1-10 www.iqurepharma.com/
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

Details

Legal Name iQure Pharma Inc.
Operating Status Active
Company Type For Profit
About the Company
iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics.
Contact Email info@iqurepharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
iQure Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

iQ-007
An orally available small molecule that enhances the function of the brain's main glutamate transporter to restore glutamate balance and reduce excitotoxicity in CNS disorders.
EAAT2 Modulator Pipeline
A pipeline of small molecule compounds targeting EAAT2 to restore glutamate balance across CNS diseases including epilepsy, neurodegeneration, and chronic pain.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
OKG Capital Logo
OKG Capital
Yes
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
OKG Capital Logo
OKG Capital
Yes
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
OKG Capital Logo
OKG Capital
Yes
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
OKG Capital Logo
OKG Capital
Yes
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
OKG Capital Logo
OKG Capital
Yes
Venture Round - iQure Pharma Logo
Venture Round - iQure Pharma
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 1 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,540
893.55%
 in past month

IT Spend

$245.3KThis year, iQure Pharma is projected to spend $245.3K on IT, according to Aberdeen.

Active Website Tech Count

18iQure Pharma is actively using 18 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is iQure Pharma's headquarters? iQure Pharma is located in Wilmington, Delaware, United States.Who invested in iQure Pharma? iQure Pharma has 8 investors including OKG Capital and  K4 Forum Mumbai Network.When was the last funding round for iQure Pharma? iQure Pharma closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are iQure Pharma's competitors? Alternatives and possible competitors to iQure Pharma may include Kriya Therapeutics, Leal Therapeutics, and  Praxis Precision Medicines.How much funding has iQure Pharma raised to date? iQure Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b4ae374 1)
|